HomeMDGL • NASDAQ
add
Madrigal Pharmaceuticals Inc
Previous close
$291.82
Day range
$288.00 - $294.40
Year range
$200.63 - $377.46
Market cap
6.46B USD
Avg Volume
370.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 137.25M | — |
Operating expense | 212.05M | 39.47% |
Net income | -73.24M | 50.36% |
Net profit margin | -53.36 | — |
Earnings per share | -3.32 | 55.01% |
EBITDA | -78.93M | 48.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 843.07M | -20.39% |
Total assets | 996.63M | -7.91% |
Total liabilities | 285.99M | 23.53% |
Total equity | 710.64M | — |
Shares outstanding | 22.20M | — |
Price to book | 9.11 | — |
Return on assets | -19.45% | — |
Return on capital | -23.27% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -73.24M | 50.36% |
Cash from operations | -88.89M | 40.40% |
Cash from investing | 163.88M | 67.13% |
Cash from financing | 8.64M | -98.49% |
Net change in cash | 83.63M | -84.00% |
Free cash flow | -70.14M | 24.60% |
About
Founded
2011
Headquarters
Website
Employees
528
